A citation-based method for searching scientific literature

Sara Jackson, Gyanendra Kumar, Anna B Banizs, Nicole Toney, Jan F Silverman, Christina M Narick, Sydney D Finkelstein. Diagn Cytopathol 2020
Times Cited: 10







List of co-cited articles
94 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Emmanuel Labourier, Alexander Shifrin, Anne E Busseniers, Mark A Lupo, Monique L Manganelli, Bernard Andruss, Dennis Wylie, Sylvie Beaudenon-Huibregtse. J Clin Endocrinol Metab 2015
156
100

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
Yuri E Nikiforov, N Paul Ohori, Steven P Hodak, Sally E Carty, Shane O LeBeau, Robert L Ferris, Linwah Yip, Raja R Seethala, Mitchell E Tublin, Michael T Stang,[...]. J Clin Endocrinol Metab 2011
504
70



Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
David L Steward, Sally E Carty, Rebecca S Sippel, Samantha Peiling Yang, Julie A Sosa, Jennifer A Sipos, James J Figge, Susan Mandel, Bryan R Haugen, Kenneth D Burman,[...]. JAMA Oncol 2019
136
60

Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations.
Dennis Wylie, Sylvie Beaudenon-Huibregtse, Brian C Haynes, Thomas J Giordano, Emmanuel Labourier. J Pathol Clin Res 2016
34
50

Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Sylvie Beaudenon-Huibregtse, Erik K Alexander, Richard B Guttler, Jerome M Hershman, Varsha Babu, Thomas C Blevins, Paul Moore, Bernard Andruss, Emmanuel Labourier. Thyroid 2014
85
50

Clinical impact of testing for mutations and microRNAs in thyroid nodules.
John Woody Sistrunk, Alexander Shifrin, Marc Frager, Ricardo H Bardales, Johnson Thomas, Norman Fishman, Philip Goldberg, Richard Guttler, Edward Grant. Diagn Cytopathol 2019
6
83

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Yuri E Nikiforov, Sally E Carty, Simon I Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L Ferris, William E Gooding, Steven P Hodak, Shane O LeBeau, N Paul Ohori,[...]. Cancer 2014
311
50

Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
Kepal N Patel, Trevor E Angell, Joshua Babiarz, Neil M Barth, Thomas Blevins, Quan-Yang Duh, Ronald A Ghossein, R Mack Harrell, Jing Huang, Giulia C Kennedy,[...]. JAMA Surg 2018
120
50


Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
370
40

The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review.
Jonathan Mark Fussey, Bijay Vaidya, Dae Kim, Jonathan Clark, Sian Ellard, Joel Anthony Smith. Clin Endocrinol (Oxf) 2019
18
40


Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
263
40

Development and Analytical Validation of an Expanded Mutation Detection Panel for Next-Generation Sequencing of Thyroid Nodule Aspirates.
Kenny K Ablordeppey, Venkata A Timmaraju, Joanna W Song-Yang, Sharon Yaqoob, Christina Narick, Alidad Mireskandari, Sydney D Finkelstein, Gyanendra Kumar. J Mol Diagn 2020
6
66

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
Yuri E Nikiforov, Sally E Carty, Simon I Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L Ferris, William E Gooding, Shane O LeBeau, N Paul Ohori, Raja R Seethala,[...]. Thyroid 2015
225
40

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
40

Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.
Andrea R Marcadis, Pablo Valderrabano, Allen S Ho, Justin Tepe, Christina E Swartzwelder, Serena Byrd, Wendy L Sacks, Brian R Untch, Ashok R Shaha, Bin Xu,[...]. Surgery 2019
22
40

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.
Marina N Nikiforova, Abigail I Wald, Somak Roy, Mary Beth Durso, Yuri E Nikiforov. J Clin Endocrinol Metab 2013
290
30

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
313
30

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
160
30

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
390
30

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
183
30

Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients.
Guido M Sclabas, Gregg A Staerkel, Suzanne E Shapiro, Bruno D Fornage, Steven I Sherman, Rena Vassillopoulou-Sellin, Jeffrey E Lee, Douglas B Evans. Am J Surg 2003
186
30

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit.
Simona Censi, Elisabetta Cavedon, Loris Bertazza, Francesca Galuppini, Sara Watutantrige-Fernando, Paola De Lazzari, Davide Nacamulli, Gianmaria Pennelli, Ambrogio Fassina, Maurizio Iacobone,[...]. Front Endocrinol (Lausanne) 2017
23
30

Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens.
Thomas J Giordano, Sylvie Beaudenon-Huibregtse, Rupali Shinde, Laura Langfield, Michelle Vinco, Walairat Laosinchai-Wolf, Emmanuel Labourier. Hum Pathol 2014
31
30

Prognostic significance of TERT promoter and BRAF mutations in TIR-4 and TIR-5 thyroid cytology.
Simona Censi, Susi Barollo, Elisabetta Grespan, Sara Watutantrige-Fernando, Jacopo Manso, Maurizio Iacobone, Eric Casal Ide, Francesca Galuppini, Ambrogio Fassina, Loris Bertazza,[...]. Eur J Endocrinol 2019
13
30

Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas.
Markus Eszlinger, Simonetta Piana, Anja Moll, Eileen Bösenberg, Alessandra Bisagni, Alessia Ciarrocchi, Moira Ragazzi, Ralf Paschke. Thyroid 2015
43
30

Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
Markus Eszlinger, Annelise Krogdahl, Sina Münz, Christian Rehfeld, Eva Magrethe Precht Jensen, Carolina Ferraz, Eileen Bösenberg, Norbert Drieschner, Markus Scholz, Laszlo Hegedüs,[...]. Thyroid 2014
71
30

Rethinking Malignancy Risk in Indeterminate Thyroid Nodules with Positive Molecular Studies: Southern California Permanente Experience.
David S Cohen, Jane E Tongson-Ignacio, Christopher M Lolachi, Vanessa S Ghaderi, Babak Jahan-Parwar, Lester D R Thompson. Otolaryngol Head Neck Surg 2019
4
75

Central role of RET in thyroid cancer.
Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
57
30

Alterations of the BRAF gene in thyroid tumors.
Raffaele Ciampi, Yuri E Nikiforov. Endocr Pathol 2005
76
30


The role of microRNA genes in papillary thyroid carcinoma.
Huiling He, Krystian Jazdzewski, Wei Li, Sandya Liyanarachchi, Rebecca Nagy, Stefano Volinia, George A Calin, Chang-Gong Liu, Kaarle Franssila, Saul Suster,[...]. Proc Natl Acad Sci U S A 2005
931
30


Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides.
Hila Benjamin, Temima Schnitzer-Perlman, Alexander Shtabsky, Christopher J VandenBussche, Syed Z Ali, Zdenek Kolar, Fabio Pagni, Dganit Bar, Eti Meiri. Cancer Cytopathol 2016
41
30


Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
Eran Brauner, Brittany J Holmes, Jeffrey F Krane, Michiya Nishino, David Zurakowski, James V Hennessey, William C Faquin, Sareh Parangi. Thyroid 2015
79
30

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
Erik K Alexander, Giulia C Kennedy, Zubair W Baloch, Edmund S Cibas, Darya Chudova, James Diggans, Lyssa Friedman, Richard T Kloos, Virginia A LiVolsi, Susan J Mandel,[...]. N Engl J Med 2012
684
30

An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
Bryan McIver, M Regina Castro, John C Morris, Victor Bernet, Robert Smallridge, Michael Henry, Laura Kosok, Honey Reddi. J Clin Endocrinol Metab 2014
141
30

Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears.
Gila Lithwick-Yanai, Nir Dromi, Alexander Shtabsky, Sara Morgenstern, Yulia Strenov, Meora Feinmesser, Vladimir Kravtsov, Marino E Leon, Marián Hajdúch, Syed Z Ali,[...]. J Clin Pathol 2017
60
30

Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
Marina N Nikiforova, Stephanie Mercurio, Abigail I Wald, Michelle Barbi de Moura, Keith Callenberg, Lucas Santana-Santos, William E Gooding, Linwah Yip, Robert L Ferris, Yuri E Nikiforov. Cancer 2018
153
30

Multiplatform molecular test performance in indeterminate thyroid nodules.
Mark A Lupo, Ann E Walts, J Woody Sistrunk, Thomas J Giordano, Peter M Sadow, Nicole Massoll, Ryan Campbell, Sara A Jackson, Nicole Toney, Christina M Narick,[...]. Diagn Cytopathol 2020
17
30

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing.
Michal Swierniak, Aleksandra Pfeifer, Tomasz Stokowy, Dagmara Rusinek, Mykola Chekan, Dariusz Lange, Jolanta Krajewska, Małgorzata Oczko-Wojciechowska, Agnieszka Czarniecka, Michal Jarzab,[...]. Mol Cell Endocrinol 2016
22
20

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K El-Naggar, Giovanni Tallini,[...]. Clin Cancer Res 2007
277
20

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.
Zhi Liu, Peng Hou, Meiju Ji, Haixia Guan, Kimberly Studeman, Kirk Jensen, Vasily Vasko, Adel K El-Naggar, Mingzhao Xing. J Clin Endocrinol Metab 2008
278
20

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Steven I Sherman, R Michael Tuttle. Thyroid 2006
20


RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Marina N Nikiforova, Roy A Lynch, Paul W Biddinger, Erik K Alexander, Gerald W Dorn, Giovanni Tallini, Todd G Kroll, Yuri E Nikiforov. J Clin Endocrinol Metab 2003
473
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.